Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07452250) titled 'Ferumoxytol-enhanced Magnetic Resonance Venography in Patients With Venous Diseases' on Feb. 28.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).

Primary Sponsor: Min Zhou

Condition: Venous Diseases

Intervention: Drug: Ferumoxytol injection

Recruitment Status: Recruiting

Phase: Phase 2

Date of First Enrollment: March 8, 2026

Target Sample Size: 50

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07452250

Published by HT Digital Content Services with pe...